Transforming growth factor beta 1 inhibits mitogen-activated protein kinase induced by basic fibroblast growth factor in smooth muscle cells. 1996

E Berrou, and M Fontenay-Roupie, and R Quarck, and F R McKenzie, and S Lévy-Toledano, and G Tobelem, and M Bryckaert
Laboratoire de Physiopathologie Cellulaire et Moléculaire, INSERM 348, Hôpital Lariboisière, Paris, France.

Stimulation of smooth muscle cells with basic fibroblast growth factor (bFGF) results in the activation of the mitogen-activated protein kinase (MAP kinase) cascade and leads to cell proliferation. We show that transforming growth factor beta 1 (TGF-beta 1), at concentrations that completely inhibited bFGF-induced mitogenic activity, decreased bFGF-induced MAP kinase activity. Under these conditions, tyrosine and threonine phosphorylations of MAP kinase were differentially affected depending on the time period of TGF-beta 1 pretreatment. After a short (30 min) TGF-beta 1 pretreatment, the bFGF-mediated increase in phosphorylation of p42mapk on threonine was inhibited, with no effect on the level of phosphotyrosine or decrease in the electrophoretic mobility of p42mapk. This suggests that TGF-beta 1 inhibited MAP kinase activity through the action of a serine/threonine phosphatase. In contrast, a longer TGF-beta 1 pretreatment (4 h) partly inhibited the bFGF-induced MAP kinase mobility shift and correlated with the inhibition of phosphorylation on both threonine and tyrosine, suggesting that long-term TGF-beta 1 treatment prevented activation of the MAP kinase cascade or directly blocked MAP kinase. The ability of long-term (4 h) but not short-term (30 min) TGF-beta 1 pretreatment to inhibit MAP kinase activity was completely dependent on protein synthesis and suggests that TGF-beta 1 inhibits MAP kinase activity by two distinct mechanisms. These findings provide a molecular basis for the growth-inhibitory action TGF-beta 1 on bFGF-induced mitogenic activity.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D009131 Muscle, Smooth, Vascular The nonstriated involuntary muscle tissue of blood vessels. Vascular Smooth Muscle,Muscle, Vascular Smooth,Muscles, Vascular Smooth,Smooth Muscle, Vascular,Smooth Muscles, Vascular,Vascular Smooth Muscles
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003513 Cycloheximide Antibiotic substance isolated from streptomycin-producing strains of Streptomyces griseus. It acts by inhibiting elongation during protein synthesis. Actidione,Cicloheximide
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004790 Enzyme Induction An increase in the rate of synthesis of an enzyme due to the presence of an inducer which acts to derepress the gene responsible for enzyme synthesis. Induction, Enzyme
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001013 Aorta, Thoracic The portion of the descending aorta proceeding from the arch of the aorta and extending to the DIAPHRAGM, eventually connecting to the ABDOMINAL AORTA. Aorta, Ascending,Aorta, Descending,Aortic Arch,Aortic Root,Arch of the Aorta,Descending Aorta,Sinotubular Junction,Ascending Aorta,Thoracic Aorta,Aortic Roots,Arch, Aortic,Ascending Aortas,Junction, Sinotubular,Root, Aortic,Sinotubular Junctions
D013552 Swine Any of various animals that constitute the family Suidae and comprise stout-bodied, short-legged omnivorous mammals with thick skin, usually covered with coarse bristles, a rather long mobile snout, and small tail. Included are the genera Babyrousa, Phacochoerus (wart hogs), and Sus, the latter containing the domestic pig (see SUS SCROFA). Phacochoerus,Pigs,Suidae,Warthogs,Wart Hogs,Hog, Wart,Hogs, Wart,Wart Hog

Related Publications

E Berrou, and M Fontenay-Roupie, and R Quarck, and F R McKenzie, and S Lévy-Toledano, and G Tobelem, and M Bryckaert
July 1999, Arteriosclerosis, thrombosis, and vascular biology,
E Berrou, and M Fontenay-Roupie, and R Quarck, and F R McKenzie, and S Lévy-Toledano, and G Tobelem, and M Bryckaert
March 2001, European journal of cell biology,
E Berrou, and M Fontenay-Roupie, and R Quarck, and F R McKenzie, and S Lévy-Toledano, and G Tobelem, and M Bryckaert
December 2002, European journal of pharmacology,
E Berrou, and M Fontenay-Roupie, and R Quarck, and F R McKenzie, and S Lévy-Toledano, and G Tobelem, and M Bryckaert
November 2004, Cancer science,
E Berrou, and M Fontenay-Roupie, and R Quarck, and F R McKenzie, and S Lévy-Toledano, and G Tobelem, and M Bryckaert
October 2011, Experimental & molecular medicine,
E Berrou, and M Fontenay-Roupie, and R Quarck, and F R McKenzie, and S Lévy-Toledano, and G Tobelem, and M Bryckaert
January 1995, Proceedings of the National Academy of Sciences of the United States of America,
E Berrou, and M Fontenay-Roupie, and R Quarck, and F R McKenzie, and S Lévy-Toledano, and G Tobelem, and M Bryckaert
March 1998, Journal of vascular surgery,
E Berrou, and M Fontenay-Roupie, and R Quarck, and F R McKenzie, and S Lévy-Toledano, and G Tobelem, and M Bryckaert
January 2000, Methods in molecular biology (Clifton, N.J.),
E Berrou, and M Fontenay-Roupie, and R Quarck, and F R McKenzie, and S Lévy-Toledano, and G Tobelem, and M Bryckaert
November 1993, Proceedings of the National Academy of Sciences of the United States of America,
E Berrou, and M Fontenay-Roupie, and R Quarck, and F R McKenzie, and S Lévy-Toledano, and G Tobelem, and M Bryckaert
November 2002, Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery,
Copied contents to your clipboard!